Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Fr | DIH Holding US receives Nasdaq deficiency notice for delayed filings | 1 | Seeking Alpha | ||
Fr | DIH HOLDING US, INC. - 8-K, Current Report | 2 | SEC Filings | ||
Fr | DIH Holding US, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q | 82 | GlobeNewswire (Europe) | NORWELL, Mass., Aug. 29, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI) received a notice on August 26, 2025, from the Listing Qualifications Staff of The Nasdaq... ► Artikel lesen | |
15.08. | DIH HOLDING US, INC. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 2 | SEC Filings | ||
08.08. | DIH appoints healthcare finance veteran Scott Burell to board | 3 | Investing.com | ||
08.08. | DIH Appoints Scott R. Burell to DIH Holding US, Inc. Board of Directors | 1 | GlobeNewswire (USA) | ||
01.08. | DIH receives deficiency letter from Nasdaq | 3 | Seeking Alpha | ||
DIH HOLDING US Aktie jetzt für 0€ handeln | |||||
01.08. | DIH HOLDING US, INC. - 8-K, Current Report | 2 | SEC Filings | ||
01.08. | DIH Holding US, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K | 167 | GlobeNewswire (Europe) | NORWELL, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI) received a notice on July 29, 2025, from the Listing Qualifications Staff of The Nasdaq... ► Artikel lesen | |
18.07. | DIH beruft Dennis Streppa in den Verwaltungsrat und zum Vorsitzenden des Prüfungsausschusses | 3 | Investing.com Deutsch | ||
18.07. | DIH appoints Dennis Streppa to board and audit committee chair | 1 | Investing.com | ||
18.07. | DIH Appoints Dennis Streppa to DIH Holding US, Inc. Board of Directors | 1 | GlobeNewswire (USA) | ||
15.07. | DIH beruft Experten für Schlaganfall-Rehabilitation in wissenschaftlichen Beirat | 1 | Investing.com Deutsch | ||
15.07. | DIH appoints stroke rehabilitation expert to scientific advisory board | 1 | Investing.com | ||
15.07. | DIH HOLDING US, INC. - 8-K, Current Report | 1 | SEC Filings | ||
01.07. | DIH Holding US, Inc.: DIH Appoints Rehazentrum Valens as a DIH Center of Excellence | 1 | GlobeNewswire (USA) | ||
01.07. | DIH HOLDING US, INC. - 8-K, Current Report | 1 | SEC Filings | ||
30.06. | DIH HOLDING US, INC. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 1 | SEC Filings | ||
30.05. | DIH Holding US ändert Vereinbarung mit Investor | 17 | Investing.com Deutsch | ||
30.05. | DIH HOLDING US, INC. - 8-K, Current Report | 1 | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SERNOVA BIOTHERAPEUTICS | 0,115 | +6,48 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,648 | -0,77 % | RedChip Companies, Inc.: NioCorp and Atossa Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | ORLANDO, FL / ACCESS Newswire / August 29, 2025 / RedChip Companies will air interviews with NioCorp Developments Ltd. (Nasdaq:NB) and Atossa Therapeutics, Inc. (Nasdaq:ATOS) on the RedChip Small Stocks... ► Artikel lesen | |
PING AN HEALTHCARE | 2,352 | +2,22 % | PA GOODDOCTOR (01833): 2025 INTERIM REPORT | ||
MOUNTAIN VALLEY MD | 0,000 | 0,00 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
CO-DIAGNOSTICS | 0,270 | +3,85 % | Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results | SALT LAKE CITY, Aug. 14, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
CYTOSORBENTS | 0,793 | -2,46 % | CytoSorbents Corporation: CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR | FDA appeal decision found no issues with DrugSorb-ATR device safety but upheld the De Novo denial, and proposes a potential path forward for market authorization... ► Artikel lesen | |
VERU | 3,250 | -3,56 % | VERU INC. - 8-K, Current Report | ||
TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update | Received clearance to proceed with pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in ChinaGranted orphan drug designation from the European Medicines... ► Artikel lesen | |
VOLITIONRX | 0,689 | +0,85 % | VolitionRx Limited Announces Second Quarter 2025 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for Friday, August 15 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev., Aug. 14, 2025 /PRNewswire/ -- VolitionRx... ► Artikel lesen | |
EKSO BIONICS | 3,870 | 0,00 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
IMUNON | 5,230 | +2,55 % | Imunon, Inc.: IMUNON Successfully Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement | LAWRENCEVILLE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that the Company... ► Artikel lesen | |
BEYOND AIR | 2,220 | +1,83 % | Beyond Air Signs New International LungFit PH Distribution Agreements, Most Notably in Japan | GARDEN CITY, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial-stage medical device and biopharmaceutical company focused on harnessing... ► Artikel lesen | |
AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
NOVACYT | 0,451 | +0,22 % | Novacyt S.A. - Liquidity Agreement Monthly Update & TVR | ||
SIEMENS HEALTHINEERS | 47,310 | -0,13 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen |